Abstract
The effect of the acute-phase response (APR) on the activity of the hepatic drug-metabolizing system (DMS) and on the binding of phenylbutazone to plasma proteins was investigated in the horse. An APR was induced by intramuscular injections of Freund's complete adjuvant in five horses and, five days later, these horses together with five clinically normal horses were shot and the right ventral lobe of each liver removed. The hepatic microsomal fractions from the liver samples ere isolated and significantly lower (p<0.01) concentrations of cytochromes P450 and b5 and activities of aniline-p-hydroxylase and aminopyrine N-demethylase (43%, 55%, 45% and 30%, respectively) were measured in the livers from the adjuvant-inflamed horses, compared to the controls. Phenylbutazone (PBZ) was administered intravenously (4.4 mg/kg) to a further four horses and plasma protein binding was measured by ultracentrifugation. Five weeks later, these horses were injected with Freund's complete adjuvant and the intravenous administration of PBZ (4.4 mg/kg) was repeated. Inflammation induced a significant increase (p<0.01) in the unbound fraction of PBZ (5.2±0.5 as against 1.4±0.6%). These results suggest that the APR depresses the hepatic DMS and reduces the binding of PBZ to plasma proteins.
Similar content being viewed by others
REFERENCES
Auer, D.E., Ng, J.C., Thompson, H.L., Inglis, S. and Seawright, A.A., 1989. Acute phase response in horses: changes in plasma cation concentration after localised tissue injury. Veterinary Record, 124, 235–239
Baggot, J.D., 1980. Distribution of antimicrobial agents in normal and diseased animals. Journal of the American Veterinary Medicine Association, 176, 1085–1090
Bakke, O.M., Draffen, C.H. and Davies, A.S., 1974. The metabolism of phenylbutazone in the rat. Xenobiotica, 4, 237–254
Blaschke, T.F., 1977. Protein binding and kinetics of drugs in liver diseases. Clinical Pharmacokinetics, 2 32–44
Blatteis, C.M., Hales, J.R.S., Fawcett, A.A. and Mashburn, T.A., 1988. Fever and regional blood flows in wethers and parturient ewes. Journal of Applied Physiology, 65, 165–172
Branch, R.A., Nies, A.S. and Shand, D.G., 1973. The disposition of propranolol VIII. General implications of the effects of liver blood flow on elimination from the perfused rat liver. Drug Metabolism and Disposition, 1, 687–690
Brater, D.C., 1988. Clinical pharmacology of NSAIDs. Journal of Clinical Pharmacology, 28, 518–523
Conney, A.H., 1986. Induction of microsomal cytochrome P-450 enzymes. Life Sciences, 39, 2493–2518
Dinarello, C.A. and Wolff, S.M., 1993. The role of interleukin-1 in disease. New England Journal of Medicine, 328, 106–113
Faigle, J.W. and Dieterle, W., 1977. The biotransformation of phenylbutazone (Butazolidin). Journal of InternalMedicine Research, 5(supplement 2), 2–14
Guengerich, F.P., Shimada, T., Umberhauer, D.R. and Martin, M.V., 1986. Structure and function of cytochrome P-450. Advances in Experimental Biology and Medicine, 197, 83–94
Highton, J., 1984. The acute phase response: a clinical perspective. Australian and New Zealand Journal of Medicine, 14, 173–178
Janicke, D.M., Cafarell, R.F. and Parker, S.W., 1985. Pharmacokinetics of Aztreonam in patients with gram-negative infections. Antimicrobial Agents and Chemotherapy, 27, 16–20
Koch-Weser, J. and Sellers, E.M., 1976. Binding of drugs to serum albumin. New England Journal of Medicine, 294, 311–316, 526- 531
Kushner, I., 1982. The phenomenon of the acute phase response. Annals of the New York Academy of Science, 389, 39–48
Lambert, M.B.T. and Kelly, P.P., 1978. The binding of phenylbutazone to bovine and horse serum albumin. Irish Journal of Medical Science, 147, 193–196
Levi, A.J., Sherlock, S. and Walker, D., 1968. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. The Lancet, 1, 1275–1279
Mazel, P., 1972. Experiments illustrating drug metabolism in vivo. In: B.N. la Du, H.G. Mandel and E.L. Way (eds), Fundamentals of Drug Metabolism and Drug Disposition, (Williams and Wilkins, Baltimore), 546–550
Mills, P.C., 1993. Aspects of inflammation and the clinical pharmacology of phenylbutazone in racing animals, PhD thesis, (University of Queensland, Australia)
Mills, P.C., Ng, J.C. and Auer, D.E., 1996. The effect of inflammation on the disposition of phenylbutazone in Thoroughbred horses. Journal of Veterinary Pharmacology and Therapeutics, 19, 475–481
Morgan, E.T., 1993. Down-regulation of multiple cytochrome P-450 gene products by inflammatory mediators in vivo. Biochemical Pharmacology, 45, 415–419
Omura, T. and Sato, R., 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2379
Perrey, K., Jonen, H.G., Kahl, G.F. and Jahnchen, B., 1976. Elimination and distribution of phenylbuta-zone in rats during the course of adjuvant-induced inflammation. Journal of Pharmacology and Experimental Therapeutics, 197, 470–477
Reinicke, C. and Klinger, W., 1971. Effects of non-steroidal anti-rheumatic agents on microsomal drug-metabolizing enzymes of rat liver. Biochemical Pharmacology, 20, 1405–1412
Renton, K.W. and Knickle, L.C., 1990. Regulation of hepatic cytochrome P-450 during infectious disease. Canadian Journal of Physiology and Pharmacology, 68, 777–781
Shah, V.P., Wallace, S.M. and Reigelman, S., 1974. Micro-ultrafiltration technique for drug-protein binding determination in plasma. Journal of Pharmaceutical Science, 63, 1364–1367
Sojka, J.E. and Brown, S.A., 1986. Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis. Journal of the American Veterinary Medicine Association, 189, 785–789
Taylor, J.B., Lees, P. and Gerring, E.L., 1981. Analysis of phenylbutazone and its metabolites by high performance liquid chromatography. Equine Veterinary Journal, 13, 201–203
Tillement, J.P., Lhoste, F. and Giudicelli, J.F., 1978. Diseases and drug protein binding. Clinical Pharmacokinetics, 3, 144–154
Tobin, T., Chay, S., Kammerling, S., Seeds, W.C., Weckman, T.J., Bake, J.W. and Lees, P., 1986. Phenylbutazone in the horse: a review. Journal of Veterinary Pharmacology and Therapeutics, 2, 1–25
van Miert, A.S.J.P.A.M., 1995. Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological and therapeutic aspects. The Veterinary Quarterly, 17, 41–50
Wilkinson, G.R. and Shand, D.G., 1975. A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics, 18, 377–390
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mills, P., Ng, J. & Auer, D. The Effect of the Acute-Phase Response on In Vitro Drug Metabolism and Plasma Protein Binding in the Horse. Vet Res Commun 21, 361–368 (1997). https://doi.org/10.1023/A:1005816422279
Issue Date:
DOI: https://doi.org/10.1023/A:1005816422279